Aptevo Therapeutics's total assets for Q4 2024 were $15.59M, an increase of 2.94% from the previous quarter. APVO total liabilities were $10.84M for the fiscal quarter, a 1.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.